HPM’s Larry Houck Speaking at Opioid and Fentanyl Abuse Management Summit

The diversion of controlled substances intended for patients by physicians, pharmacists, nurses and other trusted healthcare employees is a significant issue facing hospitals and healthcare facilities.

Controlled substances are a necessary component of medical care for patients, and recent employee diversion incidents illustrate the continued vulnerability of hospitals.  Hospitals that fail to fulfill their obligations under the federal Controlled Substances Act and DEA regulations pose serious risks to their patients for undertreatment and worse, and to their employees for overdose and death.  Employee diversion of significant controlled substance quantities from hospitals has also resulted in large civil monetary settlements, some in the millions of dollars, costly compliance remediation programs, and in unwanted local and national publicity.

HPM Director Larry Houck is presenting “Hospital/Healthcare Facility Controlled Substance Diversion: Recent Case Studies,” focusing on this timely topic, at the World Conference Forum’s 2025 Opioid & Fentanyl Abuse Management Summit in Chicago on July 17th-18th.

Attendees will learn:

• How employees in some high-profile cases were able to divert significant controlled substance quantities;
• Red flags that hospitals missed;

• Safeguards to minimize internal diversion risks; and
• Best practices for maximizing diversion detection.

Click here to learn more about WCF’s Opioid & Abuse Management Summit.